ESMO® 2026 Highlights: Presenter Vignettes – Yukinori Ozaki

Dr. Yukinori Ozaki

Yukinori Ozaki

MD, PhD

Japanese Foundation for Cancer Research

542RO

Prognostic impact of postoperative ctDNA surveillance on relapse-free survival and molecular lead time in high-risk breast cancer: JCOG1204A1